Fluoxetine-Conjugated Platinum(IV) prodrug-1 Preis auf Anfrage
Biozol Catalog Number:
MCE-HY-176149
Supplier Catalog Number:
HY-176149
Alternative Catalog Number:
MCE-HY-176149-1UNIT
Manufacturer:
MedchemExpress
Category:
Biochemikalien
Fluoxetine-Conjugated Platinum(IV) prodrug-1 (Compound 8) is an eEF2K inhibitor. Fluoxetine-Conjugated Platinum(IV) prodrug-1 inhibits cancer cell proliferation, induces DNA damage, cell cycle arrest at S phase and apoptosis. Fluoxetine-Conjugated Platinum(IV) prodrug-1 induces ROS accumulation and mitochondrial dysfunction. Fluoxetine-Conjugated Platinum(IV) prodrug-1 inhibits TNBC cell migration and invasion by inhibiting MMP-2 activity. Fluoxetine-Conjugated Platinum(IV) prodrug-1 induces autophagy in TNBC cells by activating AMPK. Fluoxetine-Conjugated Platinum(IV) prodrug-1 has antitumor activity and activates immunosuppression in the 4T1-Luc mouse model. Fluoxetine-Conjugated Platinum(IV) prodrug-1 can be used in triple-negative breast cancer (TNBC) research[1].
Molecular Weight:
725.45
Formula:
C21H28Cl2F3N3O5Pt
Target:
AMPK,Apoptosis,Autophagy,CaMK,MMP
Application Notes:
MCE Product type: Reference compound
* VAT and and shipping costs not included. Errors and price changes excepted
